Abstract
The epithelial-to-mesenchymal transition (EMT) plays a vital role in carcinogenesis, invasion, and metastasis of many epithelial tumors including oral squamous cell carcinoma (OSCC), a common malignancy of the head and neck. However, the functional role of the actin-sequestering protein thymosin β4 (Tβ4) in the EMT in OSCCs remains unclear. Thus, we investigated whether overexpression of Tβ4 could induce in vitro tumorigenesis such as cell proliferation and anchorage independency and an EMT-like phenotype in OSCCs. Also, we examined whether it affects invasiveness and cell motility-associated signaling molecules. Tβ4-overexpressing OSCCs, SCC-15_Tβ4 and SCC-25_Tβ4, enhanced cell proliferation and colony formation. In addition, we observed that Tβ4 overexpression induced an EMT-like phenotype, accompanied by a decrease in expression of the epithelial cell marker E-cadherin and an increase in expression of mesenchymal cell markers vimentin and N-cadherin. Also, the expression level of Twist1, an EMT-inducing transcription factor, was significantly enhanced in SCC-15_Tβ4 and SCC-25_Tβ4 cells. Tβ4 overexpression augmented in vitro invasion and MMP-2 activity and enhanced the phosphorylation of paxillin and cortactin and expression of LIMK1. Taken together, these results suggest that Tβ4 overexpression could be one of the causes of tumorigenesis and progression in OSCCs. Further investigation on the Tβ4 molecule would encourage the development of specific targets for cancer treatment.
Similar content being viewed by others
References
Badowski C, Pawlak G, Grichine A, Chabadel A, Oddou C, Jurdic P, Pfaff M, Albigès-Rizo C, Block MR et al (2008) Paxillin phosphorylation controls invadopodia/podosomes spatiotemporal organization. Mol Biol Cell 19(2):633–645
Batlle E, Sancho E, Franci C, Dominguez D, Monfar M, Baulida J et al (2000) The transcription factor snail is a repressor of E-cadherin gene expression in epithelial tumour cells. Nat Cell Biol 2:84–89
Bednarek R, Boncela J, Smolarczyk K, Cierniewska-Cieslak A, Wyroba E, Cierniewski CS et al (2008) Ku80 as a novel receptor for thymosin beta4 that mediates its intracellular activity different from G-actin sequestering. J Biol Chem 283(3):1534–1544
Binnie WH, Rankin KV, Mackenzie IC et al (1983) Etiology of oral squamous cell carcinoma. J Oral Pathol 12(1):11–29
Bodner L, Manor E, Friger MD, van der Waal I et al (2014) Oral squamous cell carcinoma in patients 20 years of age or younger—review and analysis of 186 reported cases. Oral Oncol 50(2):84–89
Bowden ET, Onikoyi E, Slack R, Myoui A, Yoneda T, Yamada KM, Mueller SC et al (2006) Co-localization of cortactin and phosphotyrosine identifies active invadopodia in human breast cancer cells. Exp Cell Res 312(8):1240–1253
Brieger A, Plotz G, Zeuzem S, Trojan J et al (2007) Thymosin beta 4 expression and nuclear transport are regulated by hMLH1. Biochem Biophys Res Commun 364(4):731–736
Cano A, Perez-Moreno MA, Rodrigo I, Locascio A, Blanco MJ, del Barrio MG et al (2000) The transcription factor snail controls epithelial-mesenchymal transitions by repressing E-cadherin expression. Nat Cell Biol 2:76–83
Carlier MF, Didry D, Erk I, Lepault J, Van Troys ML, Vandekerckhove J, Perelroizen I, Yin H, Doi Y, Pantaloni D et al (1996) Tβ4 is not a simple G-actin sequestering protein and interacts with F-actin at high concentration. J Biol Chem 271(16):9231–9239
Chao TC, Chen KJ, Tang MC, Chan LC, Chen PM, Tzeng CH, Su Y et al (2014) Thymosin beta-4 knockdown in IEC-6 normal intestinal epithelial cells induces DNA re-replication via downregulating Emi1. J Cell Physiol 229(11):1639–1646
Condeelis J, Singer RH, Segall JE et al (2005) The great escape: when cancer cells hijack the genes for chemotaxis and motility. Annu Rev Cell Dev Biol 21:695–718
Daly RJ (2004) Cortactin signalling and dynamic actin networks. Biochem J 382(Pt 1):13–25
Dantas DD, Ramos CC, Costa AL, Souza LB, Pinto LP et al (2003) Clinical–pathological parameters in squamous cell carcinoma of the tongue. Braz Dent J 14(1):22–25
Deakin NO, Pignatelli J, Turner CE et al (2012) Diverse roles for the paxillin family of proteins in cancer. Genes Cancer 3(5–6):362–370
Efstathiou JA, Liu D, Wheeler JM, Kim HC, Beck NE, Ilyas M et al (1999) Mutated epithelial cadherin is associated with increased tumorigenicity and loss of adhesion and of responsiveness to the motogenic trefoil factor 2 in colon carcinoma cells. Proc Natl Acad Sci USA 96:2316–2321
Foletta VC, Moussi N, Sarmiere PD, Bamburg JR, Bernard O et al (2004) LIM kinase 1, a key regulator of actin dynamics, is widely expressed in embryonic and adult tissues. Exp Cell Res 294(2):392–405
Grant DS, Kinsella JL, Kibbey MC, LaFlamme S, Burbelo PD et al (1995) Matrigel induces thymosin beta 4 gene in differentiating endothelial cells. J Cell Sci 108:3685–3694
Grant DS, Rose W, Yaen C, Goldstein A, Martinez J et al (1999) Thymosin beta 4 enhances endothelial cell differentiation and angiogenesis. Angiogenesis 2:125–135
Haas BR, Cuddapah VA, Watkins S, Rohn KJ, Dy TE, Sontheimer H et al (2011) With-No-Lysine Kinase 3 (WNK3) stimulates glioma invasion by regulating cell volume. Am J Physiol Cell Physiol 301(5):C1150–C1160
Hall AK (1991) Differential expression of thymosin genes in human tumors and in the developing human kidney. Int J Cancer 48(5):672–677
Huang HC, Hu CH, Tang MC, Wang WS, Chen PM, Su Y et al (2007a) Thymosin β4 triggers an epithelial-mesenchymal transition in colorectal carcinoma by upregulating integrin-linked kinase. Oncogene 26(19):2781–2790
Huang CL, Cha SK, Wang HR, Xie J, Cobb MH et al (2007b) WNKs: protein kinases with a unique kinase domain. Exp Mol Med 39(5):565–573
Iguchi K, Ito M, Usui S, Mizokami A, Namiki M, Hirano K et al (2008) Downregulation of thymosin β4 expression by androgen in prostate cancer LNCaP cells. J Androl 29(2):207–212
Kalluri R, Weinberg RA (2009) The basics of epithelial-mesenchymal transition. J Clin Invest 119:1420–1428
Kim A, Son M, Kim KI, Yang Y, Song EY, Lee HG, Lim JS et al (2009) Elevation of intracellular cyclic AMP inhibits NF-kappaB-mediated thymosin beta4 expression in melanoma cells. Exp Cell Res 315(19):3325–3335
Lee SJ, So IS, Park SY, Kim IS et al (2008) Thymosin beta4 is involved in stabilin-2-mediated apoptotic cell engulfment. FEBS Lett 582(15):2161–2166
Lee SI, Kim DS, Lee HJ, Cha HJ, Kim EC et al (2013) The role of thymosin beta 4 on odontogenic differentiation in human dental pulp cells. PLoS One 8(4):e61960
Li X, Zheng L, Peng F, Qi C, Zhang X, Zhou A, Liu Z, Wu S et al (2007) Recombinant thymosin beta 4 can promote full-thickness cutaneous wound healing. Protein Expr Purif 56(2):229–236
Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25(4):402–408
McConnell BV, Koto K, Gutierrez-Hartmann A et al (2011) Nuclear and cytoplasmic LIMK1 enhances human breast cancer progression. Mol Cancer 18(10):75
Moniz S, Jordan P (2010) Emerging roles for WNK kinases in cancer. Cell Mol Life Sci 67(8):1265–1276
Nakanishi K, Sakamoto M, Yasuda J, Takamura M, Fujita N, Tsuruo T, Todo S, Hirohashi S et al (2002) Critical involvement of the phosphatidylinositol 3-kinase/Akt pathway in anchorage-independent growth and hematogeneous intrahepatic metastasis of liver cancer. Cancer Res 62(10):2971–2975
Nemolato S, Restivo A, Cabras T, Coni P, Zorcolo L, Orrù G, Fanari M, Cau F, Gerosa C, Fanni D, Messana I, Castagnola M, Casula G, Faa G et al (2012) Thymosin β 4 in colorectal cancer is localized predominantly at the invasion front in tumor cells undergoing epithelial esenchymal transition. Cancer Biol Ther 13(4):191–197
Noguti J, De Moura CF, De Jesus GP, Da Silva VH, Hossaka TA, Oshima CT et al (2012) Metastasis from oral cancer: an overview. Cancer Genomics Proteomics 9(5):329–335
Nummela P, Yin M, Kielosto M, Leaner V, Birrer MJ, Holtta E et al (2006) Thymosin β4 is a determinant of the transformed phenotype and invasiveness of S-adenosylmethionine decarboxylase-transfected fibroblasts. Cancer Res 66(2):701–712
Oh JM, Ryoo IJ, Yang Y, Kim HS, Yang KH, Moon EY et al (2008) Hypoxia-inducible transcription factor (HIF)-1 alpha stabilization by actin-sequestering protein, thymosin β4 (Tββ4) in Hela cervical tumor cells. Cancer Lett 264(1):29–35
Olasz L, Szalma J, Orsi E, Tornoczky T, Marko T, Nyarady Z et al (2010) Neoadjuvant chemotherapy: does it have benefits for the surgeon in the treatment of advanced squamous cell cancer of the oral cavity? Pathol Oncol Res: POR 16(2):207–212
Orlichenko LS, Radisky DC (2008) Matrix metalloproteinases stimulate epithelial-mesenchymal transition during tumor development. Clin Exp Metastasis 25(6):593–600
Oser M, Mader CC, Gil-Henn H, Magalhaes M, Bravo-Cordero JJ, Koleske AJ, Condeelis J et al (2010) Specific tyrosine phosphorylation sites on cortactin regulate Nck1-dependent actin polymerization in invadopodia. J Cell Sci 123:3662–3673
Philp D, Goldstein AL, Kleinman HK et al (2004) Thymosin beta 4 promotes angiogenesis, wound healing, and hair follicle development. Mech Ageing Dev 125:113–125
Piao Z, Hong CS, Jung MR, Choi C, Park YK et al (2014) Thymosin β4 induces invasion and migration of human colorectal cancer cells through the ILK/AKT/β-catenin signaling pathway. Biochem Biophys Res Commun 452(3):858–864
Proia NK, Paszkiewicz GM, Nasca MA, Franke GE, Pauly JL et al (2006) Smoking and smokeless tobacco-associated human buccal cell mutations and their association with oral cancer—a review. Cancer Epidemiol Biomarkers Prev 15(6):1061–1077
Qiu P, Wheater MK, Qiu Y, Sosne G et al (2011) Thymosin beta4 inhibits TNF-alpha-induced NF-kappaB activation, IL-8 expression, and the sensitizing effects by its partners PINCH-1 and ILK. FASEB J 25(6):1815–1826
Ricci-Vitiani L, Mollinari C, di Martino S, Biffoni M, Pilozzi E, Pagliuca A, de Stefano MC, Circo R, Merlo D, De Maria R, Garaci E et al (2010) Thymosin beta4 targeting impairs tumorigenic activity of colon cancer stem cells. FASEB J 24(11):4291–4301
Ryu YK, Lee YS, Lee GH, Song KS, Kim YS, Moon EY et al (2012) Regulation of glycogen synthase kinase-3 by thymosin beta-4 is associated with gastric cancer cell migration. Int J Cancer 131(9):2067–2077
Sahai E (2005) Mechanisms of cancer cell invasion. Curr Opin Genet Dev 15(1):87–96
Selbach M, Backert S (2005) Cortactin: an Achilles’ heel of the actin cytoskeleton targeted by pathogens. Trends Microbiol 13(4):181–189
Sribenja S, Wongkham S, Wongkham C, Yao Q, Chen C et al (2013) Roles and mechanisms of β-thymosins in cell migration and cancer metastasis: an update. Cancer Invest 31(2):103–110
Summy JM, Gallick GE (2003) Src family kinases in tumor progression and metastasis. Cancer Metastasis Rev 22(4):337–358
Tapia T, Ottman R, Chakrabarti R et al (2011) LIM kinase1 modulates function of membrane type matrix metalloproteinase 1: implication in invasion of prostate cancer cells. Mol Cancer 10(10):6
Thiery JP, Sleeman JP (2006) Complex networks orchestrate epithelial mesenchymal transitions. Nat Rev Mol Cell Biol 7:131–142
Thiery JP, Acloque H, Huang RY, Nieto MA et al (2009) Epithelial-mesenchymal transitions in development and disease. Cell 139:871–890
Tokura Y, Nakayama Y, Fukada S, Nara N, Yamamoto H et al (2011) Muscle injury-induced thymosin b4 acts as a chemoattractant for myoblasts. J Biochem 149:43–48
Vigneswaran N, Wu J, Sacks P, Gilcrease M, Zacharias W et al (2005) Microarray gene expression profiling of cell lines from primary and metastatic tongue squamous cell carcinoma: possible insights from emerging technology. J Oral Pathol Med 34(2):77–86
Vitari AC, Deak M, Collins BJ, Morrice N, Prescott AR, Phelan A, Humphreys S, Alessi DR et al (2004) WNK1, the kinase mutated in an inherited high-blood-pressure syndrome, is a novel PKB (protein kinase B)/Akt substrate. Biochem J 378(1):257–268
Wang WS, Chen PM, Hsiao HL, Ju SY, Su Y et al (2003) Overexpression of the thymosin beta-4 gene is associated with malignant progression of SW480 colon cancer cells. Oncogene 22(21):3297–3306
Wang ZY, Zeng FQ, Zhu ZH, Jiang GS, Lv L, Wan F, Dong R, Xiao XY, Xing SA et al (2012) Evaluation of thymosin β4 in the regulation of epithelial-mesenchymal ransformation in urothelial carcinoma. Urol Oncol 30(2):167–176
Warnakulasuriya S (2009) Global epidemiology of oral and oropharyngeal cancer. Oral Oncol 45(4–5):309–316
Wheeler JM, Kim HC, Efstathiou JA, Ilyas M, Mortensen NJ, Bodmer WF et al (2001) Hypermethylation of the promoter region of the E-cadherin gene (CDH1) in sporadic and ulcerative colitis associated colorectal cancer. Gut 48:367–371
Wirsching HG, Krishnan S, Florea AM, Frei K, Krayenbühl N, Hasenbach K, Reifenberger G, Weller M, Tabatabai G et al (2014) Thymosin β 4 gene silencing decreases stemness and invasiveness in glioblastoma. Brain 137(Pt 2):433–448
Xu TJ, Wang Q, Ma XW, Zhang Z, Zhang W, Xue XC, Zhang C, Hao Q, Li WN, Zhang YQ, Li M et al (2013) A novel dimeric thymosin beta 4 with enhanced activities accelerates the rate of wound healing. Drug Des Devel Ther 7:1075–1088
Yamaguchi H, Wyckoff J, Condeelis J et al (2005) Cell migration in tumors. Curr Opin Cell Biol 17(5):559–564
Yang J, Weinberg RA (2008) Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis. Dev Cell 14:818–829
Yoshioka K, Foletta V, Bernard O, Itoh K et al (2003) A role for LIM kinase in cancer invasion. Proc Natl Acad Sci U S A 100(12):7247–7252
Yu CC, Tsai LL, Wang ML, Yu CH, Lo WL, Chang YC, Chiou GY, Chou MY, Chiou SH et al (2013) miR145 targets the SOX9/ADAM17 axis to inhibit tumor-initiating cells and IL-6-mediated paracrine effects in head and neck cancer. Cancer Res 73(11):3425–3440
Zhang Y, Feurino LW, Zhai Q, Wang H, Fisher WE, Chen C, Yao Q, Li M et al (2008) Thymosin β4 is overexpressed in human pancreatic cancer cells and stimulates proinflammatory cytokine secretion and JNK activation. Cancer Biol Ther 7(3):419–423
Zhong LP, Zhang CP, Ren GX, Guo W, William WN Jr, Sun J et al (2013) Randomized phase III trial of induction chemotherapy with docetaxel, cisplatin, and fluorouracil followed by surgery versus up-front surgery in locally advanced resectable oral squamous cell carcinoma. J Clin Oncol 31(6):744–751
Acknowledgments
This work was supported by a National Research Foundation of Korea (NRF) grant funded by the Ministry of Education, Science and Technology (NRF-2012R1A1A2005080).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Handling Editor: G. J. Peters.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Hong, KO., Lee, JI., Hong, SP. et al. Thymosin β4 induces proliferation, invasion, and epithelial-to-mesenchymal transition of oral squamous cell carcinoma. Amino Acids 48, 117–127 (2016). https://doi.org/10.1007/s00726-015-2070-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00726-015-2070-6